Library > Country Reports > Europe



This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country  located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical…

This report offers companies, investors, policymakers, and stakeholders crucial insight into Ireland; a nation that stands poised to cement its position as a premier pharmaceuticals power, not just within Europe, but globally. In addition to its blossoming R&D…

This special report offers companies, investors, policymakers, and stakeholders crucial insight into Central and Eastern Europe (CEE): a dynamic region, located strategically at the crossroads between Western Europe and the East, that has largely recovered from the global…

This report offers companies, investors, policymakers, and stakeholders crucial insight into Luxembourg; a country that is rapidly breaking away from its reputation as simply a tiny European tax haven and establishing itself as a serious regional and global healthcare and…

This report offers companies, investors, policymakers, and stakeholders crucial insight into Slovakia; a country with both political and economic stability; a Eurozone member that stands out in its region for being a member of the single currency; and, for the second half of…

This report offers companies, investors, policymakers, and stakeholders crucial insight into Switzerland; a country  located at the heart of Europe, home to some of the world’s most important international health institutions as well as two of its largest pharmaceutical…

This report offers companies, investors, policymakers, and stakeholders crucial insight into the Czech Republic; a country transforming itself from merely a producer of cheap generics to the regional headquarters of some of the largest pharmaceutical companies in the world.…

The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts…

This report offers companies, investors, policymakers, and stakeholders crucial insight into Hungary; a country with more than 100 years of history in pharmaceuticals and a leading regional role in the industry. Regulatory reform post-2008 has seen Hungary weather the storm…

This report offers companies, investors, policymakers, and stakeholders crucial insight into the birthplace of the modern pharmaceutical industry; a country that has transitioned out of economic recession and is now benefiting from its prime geographic position, tradition…

The report features interviews with the global head of Ipsen, a representative of the IMS, and of the French pricing agency CEPS. Also included are interviews with leading figures from public institutions and private companies, comprehensive articles, and up-to-date facts…

The report offers companies, investors, policymakers, and stakeholders crucial insight into a country at the global forefront of healthcare, pharmaceutical and biotechnological innovation. It features an exclusive in-depth interview with Europe’s longest-standing Minister…

We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here